Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
24.17
-1.33 (-5.22%)
At close: Nov 16, 2026, 4:00 PM EST
24.22
+0.05 (0.21%)
After-hours: Nov 16, 2026, 7:30 PM EST
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $4.1 billion as of November 16, 2026. It is the 4,109th most valuable company in the world and the 1,298th biggest in the United States. Its market cap has increased by 272.46% in one year.
Market Cap
4.10B
Enterprise Value
3.15B
1-Year Change
272.46%
Global Rank
Country Rank
#1,298 United States
Category
ChartMarket Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $4.10B, an increase of 2,520.33%. That is a compound annual growth rate of 79.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 4.10B | 243.24% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 5.03B |
| Cogent Biosciences | 4.97B |
| Travere Therapeutics | 4.86B |
| Ionis Pharmaceuticals | 4.84B |
| Definium Therapeutics | 4.39B |
| CRISPR Therapeutics AG | 4.10B |
| Relay Therapeutics | 4.00B |
| Xenon Pharmaceuticals | 3.98B |